Viatris (VTRS) Retained Earnings (2019 - 2026)

Viatris' (VTRS) quarterly Retained Earnings came in at $18.7 billion in Q1 2026, down 1.57% year-on-year from $19.0 billion in Q1 2025, and down 0.73% quarter-over-quarter from $18.8 billion in Q4 2025.

Viatris (VTRS) Retained Earnings (2019 - 2026) Analysis & Trends

Viatris' Retained Earnings history runs 8 years deep, the most recent figure standing at $18.7 billion for Q1 2026.

  • On a quarterly basis, Retained Earnings fell 1.57% year-over-year to $18.7 billion in Q1 2026; TTM through Mar 2026 was $18.7 billion, a 1.57% decrease from a year earlier, with the FY2025 full-year figure at $18.8 billion, down 0.64% from the prior year.
  • Retained Earnings declined to $18.7 billion in Q1 2026 per VTRS's latest filing, from $18.8 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at $19.0 billion in Q1 2025 and bottomed at -$3.8 billion in Q3 2022.
  • The 5-year median for Retained Earnings is -$2.7 billion (2025), against an average of $6.1 billion.
  • Across the five-year window, Retained Earnings tumbled 155.39% in 2022 and soared 781.4% in 2023, its largest moves.
  • Year by year, Retained Earnings stood at -$2.8 billion in 2022, then soared by 781.4% to $18.8 billion in 2023, then grew by 0.57% to $18.9 billion in 2024, then decreased by 0.64% to $18.8 billion in 2025, then fell by 0.73% to $18.7 billion in 2026.
  • Per Business Quant, the three latest VTRS Retained Earnings figures stand at $18.7 billion (Q1 2026), $18.8 billion (Q4 2025), and $18.9 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - 37.04 Bn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 28.20 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 1.11 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 4.54 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 8.83 Bn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -413.76 Mn
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 18.66 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 589.60 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -2.13 Bn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn -319.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.66 Bn
Dec 31, 2025 18.80 Bn
Sep 30, 2025 18.89 Bn
Jun 30, 2025 -2.66 Bn
Mar 31, 2025 18.96 Bn
Dec 31, 2024 18.92 Bn
Sep 30, 2024 18.89 Bn
Jun 30, 2024 -2.98 Bn
Mar 31, 2024 -2.94 Bn
Dec 31, 2023 18.81 Bn
Sep 30, 2023 -3.21 Bn
Jun 30, 2023 -3.01 Bn
Mar 31, 2023 -2.76 Bn
Dec 31, 2022 -2.76 Bn
Sep 30, 2022 -3.76 Bn
Jun 30, 2022 -2.90 Bn
Mar 31, 2022 -2.06 Bn
Dec 31, 2021 -1.74 Bn
Sep 30, 2021 -1.47 Bn
Jun 30, 2021 -1.21 Bn